HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Christopherson, W. M. Articles by Parker, J. E. Search for Related Content PubMed PubMed Citation Articles by Christopherson, W. M. Articles by Parker, J. E.

CA: A Cancer Journal for Clinicians, Vol 19, 107-111, Copyright © 1969 by American Cancer Society

Economic Considerations of the Control of Cervix Cancer in High Risk Patients

¹ Professor and Chairman, Department of Pathology, the University of Louisville School of Medicine, Louisville, Kentucky.
² Associate Professor of Pathology, the University of Louisville School of Medicine.

Cervix cancer is a controllable disease. The cost of early detection by routine cytological screening is significant but within the means of many, if not most countries. Where the high cost of cancer control presents a major problem, high risk groups can be identified and selected for screening, thus cutting the cost to reasonable levels. Our study is in full agreement with the more detailed analysis performed by the Cancer Control Program of the U. S. Public Health Service. We conclude, therefore, that cost should not interfere with the control of cervix cancer. We can afford it!